COVID-19: The Invisible Impact on Dermatologists and Dermatology Practices
This webinar was previously recorded on May 13th, 2020 and is now available on demand.
Join colleagues and thought leaders as we examine the emotional and logistical impact of COVID-19 on employees. Panelists will discuss job loss, mental wellbeing, employee’s top concerns and communication surrounding the global coronavirus pandemic.
Experts will discuss ways to offset anxiety and depression, steps to take care of your emotional well-being and logistical challenges such as homeschooling and balancing the ever-changing priorities during this crisis. There will also be discussion surrounding manager communication strategies, what works, what does not work and ways employers can calm employee’s fears during the pandemic.
Moderator
- Brandon Thompson
(Co-Founder, Careers in Aesthetics & Co-Founder & CEO, BNB Aesthetic Innovations)
Faculty
- Richard G. Fried, MD, PhD
(Board Certified Dermatologist & Clinical Psychologist, Clinical Director, Yardley Dermatology Associates) - John Connors
(CEO & President, Jan Marini Skin Research) - Mark Wilkins
(Executive Vice President and U.S. General Manager, Prollenium Medical Technologies) - Aaron Burton
(CEO, Sciton) - Jenna Mons Anderson
(CEO, AccessElite)
You May Also Like
From the Vault: Integrated Short-Term and Long-Term Efficacy of Topical Clascoterone Cream 1% in Patients Aged 12 Years or Older With Acne Vulgaris
Clascoterone Keeps Gaining Ground in Acne Two identical Phase 3 trials (plus a long‑term extension) randomized patients ≥12 years with moderate‑to‑severe acne to twice‑daily clascoterone 1% cream or vehicle for…
Microneedling Combined With Drugs and Stem Cells for Treating Androgenetic Alopecia
Small Channels, Smarter Delivery - A Practical Boost For Topical And Regenerative Approaches Microneedling is proving to be a low‑risk, clinic-friendly way to enhance topical therapies (most consistently 5% minoxidil, now…
The Prevalence of Dupilumab-Associated Adverse Events Among Black and African American Adult Patients With Atopic Dermatitis: A Retrospective Chart Review
Dupilumab in Diverse Skin — Are Adverse Events Really the Same? Atopic dermatitis isn’t one-size-fits-all: chronic type 2 inflammation, barrier dysfunction, and S. aureus colonization are core features, but presentation…
